AI assistant
Calliditas Therapeutics Major Shareholding Notification 2019
3020_iss_2019-07-03_210555f0-bc39-41e7-bf35-8f409adbe41a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Calliditas Therapeutics AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 1,376,727 |
| Voting rights | 1,376,727 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 03/07/2019 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,101,727 |
| Directly held voting rights | 2,101,727 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.97 % |
| Directly held voting rights | 5.97 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.97 % | 2,101,727 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.97 % | 2,101,727 |
Group total holdings
Voting rights 2,101,727 Percentage of voting rights 5.97
Notes (other relevant informations according to law)
Flaggning baseras på befintligt antal utestående aktier. När de nyemitterade aktierna registreras kommer AP4 äga 5,43% av kapital och röster.
Published
03/07/2019 10:51
Contact
Name Jannis Kitsakis Phone 070-6038023 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25